WorldPharmaNews
  • Home
  • Business
  • Research
  • Jobs
  • Events
  • Regulatory

Pfizer

PfizerAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us.

www.pfizer.com

Filters
List of articles in category Pfizer
Title Published Date
Pfizer to Acquire Coley Pharmaceutical Group 16 November 2007
Lipitor Demonstrated Significant Improvement or Stabilization of Kidney Function 06 November 2007
Taisho and Pfizer Sign a Letter of Intent for Taisho’s Schizophrenia Drug Candidate 03 November 2007
Pfizer to Appeal German Court Decision in Lipitor Patent Case 30 October 2007
Spanish Appellate Court Rules in Pfizer's Favor, Upholds Lipitor Patent 23 October 2007
Pfizer Reports Third-Quarter 2007 Results 19 October 2007
Pfizer Engages with Nation's Physicians Through Sermo to Improve Patient Care 15 October 2007
Pfizer Launches Independent Biotherapeutics and Bioinnovation Center 05 October 2007
Anti-Tumor Activity of Single-Agent Sunitinib Malate in Advanced Gastric Cancer 28 September 2007
First in a New Oral Class of HIV Medicines in 10 Years 24 September 2007
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug 19 September 2007
Global Phase III Trial to Evaluate Sunitinib Malate Combined with Erlotinib 12 September 2007
Pfizer Launches Five Year, Three Country Initiative for Malaria Treatment and Education 06 September 2007
Significant 30 Percent Increase in Relative Risk of Cardiovascular Events or Death 05 September 2007
Pfizer Names Frank A. D'Amelio Chief Financial Officer 22 August 2007
UK Body Recommends Pfizer's Champix (varenicline) for Smokers 30 May 2007
  • Start
  • Prev
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next
  • End

Business & Industry

  • Bayer exercised option to obtain full licensing rights for larotrectinib and BAY 2731954 (LOXO-195)
  • Boehringer Ingelheim (Canada) Ltd. and IBM Canada announce first of its kind collaboration to integrate blockchain technology into clinical trials
  • Merz delivers double-digit growth in strategic business areas
  • The Union for International Cancer Control and Pfizer announce new phase of global grants initiative supporting metastatic breast cancer patients
  • Merck to expand US biopharmaceutical R&D facility to advance innovative clinical pipeline

Research & Development

  • Researchers develop reversible antiplatelet therapy to fight clotting, cancer metastasis
  • How Viagra puts a brake on a master growth regulator to treat heart disease
  • Nano drops a million times smaller than a teardrop explodes 19th century theory
  • New insight into cell receptors opens the way for tailored cancer drugs
  • New pill can deliver insulin
  • Simple drug combination creates new neurons from neighboring cells
  • Cannabinoid compounds may inhibit growth of colon cancer cells

Conferences & Events

  • eyeforpharma Barcelona Conference, Expo & Awards 2019
  • SMi presents the 2nd Annual Conference: Injectable Drug Delivery 2019
  • 21st Annual Superbugs & Superdrugs Conference
  • SMi Group announces the 10th Annual RNA Therapeutics Conference
  • Pre-Filled Syringes & Injectable Drug Devices Europe 2018
  • Social Media in the Pharmaceutical Industry Conference 2019
  • Lyophilization USA Conference 2018

Regulatory Affairs

  • FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain
  • FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer's disease
  • FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder
  • FDA approves first generic Advair Diskus
  • FDA approves first treatment for rare blood disease
  1. You are here:  
  2. Home
  3. Pfizer
  4. The Union for International Cancer Control and Pfizer announce new phase of global grants initiative supporting metastatic breast cancer patients

About

  • Home
  • Advertise
  • Privacy
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2006 - 2017. All Rights Reserved. WORLD PHARMA JOBS | PharmaNews.eu | eHealthNews.eu | (HEALTH IT) SPACE